Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra J Sinclair

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
Neurology|June 17, 2026
Identifying MicroRNA Biomarkers in Idiopathic Intracranial Hypertension: A Pilot StudyLisa J Hill, Ghazala Begum, Chloe N Thomas, et al.
Brain Communications|October 27, 2021
Cognitive performance in idiopathic intracranial hypertension and relevance of intracranial pressureOlivia Grech, Andrew Clouter, James L Mitchell, et al.
Neurology and Therapy|December 18, 2025
Moderate to Severe Acute Migraine Attacks: An Opinion Paper on the Use of Triptans and Triptan-NSAIDs Combinations in Individualized Treatment PlansPeter J Goadsby, Alexandra J Sinclair, Shazia K Afridi, et al.
Brain Communications|January 23, 2026
Biofluid-based predictors of post-concussion symptoms: a narrative review of mild traumatic brain injury biomarkersHannah S Lyons, Jessica C Hubbard, Chloe N Thomas, et al.
The Journal of Headache and Pain|June 11, 2022
European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention - 2022 updateSimona Sacco, Faisal Mohammad Amin, Messoud Ashina, et al.
JCI Insight|April 13, 2021
Systemic and adipocyte transcriptional and metabolic dysregulation in idiopathic intracranial hypertensionConnar Sj Westgate, Hannah F Botfield, Zerin Alimajstorovic, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 16, 2018
Idiopathic intracranial hypertension: consensus guidelines on managementSusan P Mollan, Brendan Davies, Nick C Silver, et al.
JCI Insight|February 13, 2019
A unique androgen excess signature in idiopathic intracranial hypertension is linked to cerebrospinal fluid dynamicsMichael W O'Reilly, Connar Sj Westgate, Catherine Hornby, et al.
The Journal of Clinical Endocrinology and Metabolism|October 24, 2020
11βHSD1 Inhibition with AZD4017 Improves Lipid Profiles and Lean Muscle Mass in Idiopathic Intracranial HypertensionRowan S Hardy, Hannah Botfield, Keira Markey, et al.
Brain Communications|September 21, 2020
11β-Hydroxysteroid dehydrogenase type 1 inhibition in idiopathic intracranial hypertension: a double-blind randomized controlled trialKeira Markey, James Mitchell, Hannah Botfield, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Neurology|June 17, 2026
Identifying MicroRNA Biomarkers in Idiopathic Intracranial Hypertension: A Pilot StudyLisa J Hill, Ghazala Begum, Chloe N Thomas, et al.
Brain Communications|October 27, 2021
Cognitive performance in idiopathic intracranial hypertension and relevance of intracranial pressureOlivia Grech, Andrew Clouter, James L Mitchell, et al.
Neurology and Therapy|December 18, 2025
Moderate to Severe Acute Migraine Attacks: An Opinion Paper on the Use of Triptans and Triptan-NSAIDs Combinations in Individualized Treatment PlansPeter J Goadsby, Alexandra J Sinclair, Shazia K Afridi, et al.
Brain Communications|January 23, 2026
Biofluid-based predictors of post-concussion symptoms: a narrative review of mild traumatic brain injury biomarkersHannah S Lyons, Jessica C Hubbard, Chloe N Thomas, et al.
The Journal of Headache and Pain|June 11, 2022
European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention - 2022 updateSimona Sacco, Faisal Mohammad Amin, Messoud Ashina, et al.
JCI Insight|April 13, 2021
Systemic and adipocyte transcriptional and metabolic dysregulation in idiopathic intracranial hypertensionConnar Sj Westgate, Hannah F Botfield, Zerin Alimajstorovic, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 16, 2018
Idiopathic intracranial hypertension: consensus guidelines on managementSusan P Mollan, Brendan Davies, Nick C Silver, et al.
JCI Insight|February 13, 2019
A unique androgen excess signature in idiopathic intracranial hypertension is linked to cerebrospinal fluid dynamicsMichael W O'Reilly, Connar Sj Westgate, Catherine Hornby, et al.
The Journal of Clinical Endocrinology and Metabolism|October 24, 2020
11βHSD1 Inhibition with AZD4017 Improves Lipid Profiles and Lean Muscle Mass in Idiopathic Intracranial HypertensionRowan S Hardy, Hannah Botfield, Keira Markey, et al.
Brain Communications|September 21, 2020
11β-Hydroxysteroid dehydrogenase type 1 inhibition in idiopathic intracranial hypertension: a double-blind randomized controlled trialKeira Markey, James Mitchell, Hannah Botfield, et al.
Pageof 12